PMID- 28950356 OWN - NLM STAT- MEDLINE DCOM- 20190204 LR - 20190215 IS - 2058-1742 (Electronic) IS - 2058-1742 (Linking) VI - 4 IP - 1 DP - 2018 Jan 1 TI - New York Heart Association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome. PG - 51-58 LID - 10.1093/ehjqcco/qcx031 [doi] AB - AIMS: The New York Heart Association functional classification (NYHA class) is often used to describe the functional capacity of adults with congenital heart disease (ACHD), albeit with limited evidence on its validity in this heterogeneous population. We aimed to validate the NYHA functional classification in ACHD by examining its relation to objective measures of limitation using cardiopulmonary exercise testing (CPET) and mortality. METHODS AND RESULTS: This study included all ACHD patients who underwent a CPET between 2005 and 2015 at the Royal Brompton, in whom functional capacity was graded according to the NYHA classification. Congenital heart diagnoses were classified according to the Bethesda score. Time to all-cause mortality from CPET was recorded in all 2781 ACHD patients (mean age 33.8 +/- 14.2 years) enrolled in the study. There was a strong relation between NYHA class and peak oxygen consumption (peak VO2), ventilation per unit in carbon dioxide production (VE/VCO2) slope and the Bethesda classification (P < 0.0001). Although a large number of 'asymptomatic' (NYHA class 1) patients did not achieve a 'normal' peak VO2, the NYHA class was a strong predictor of mortality, with an 8.7-fold increased mortality risk in class 3 compared with class 1 (hazard ratio 8.68, 95% confidence interval: 5.26-14.35, P < 0.0001). CONCLUSION: Despite underestimating the degree of limitation in some ACHD patients, NYHA classification remains a valuable clinical tool. It correlates with objective measures of exercise and the severity of underlying cardiac disease, as well as mid- to long-term mortality and should, thus, be into incorporated the routine assessment and risk stratification of these patients. CI - Published on behalf of the European Society of Cardiology. All rights reserved. (c) The Author 2017. For permissions please email: journals.permissions@oup.com. FAU - Bredy, Charlene AU - Bredy C AD - Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Harefield NHS Foundation Trust, Sydney Street, SW3 6NP London, UK. AD - National Heart and Lung Institute, Imperial College London, UK. AD - Department of Cardiology, Montpellier University Hospital, Montpellier, France. FAU - Ministeri, Margherita AU - Ministeri M AD - Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Harefield NHS Foundation Trust, Sydney Street, SW3 6NP London, UK. AD - National Heart and Lung Institute, Imperial College London, UK. AD - Centro Cuore Morgani Pedara, Catania, Italy. FAU - Kempny, Alexander AU - Kempny A AD - Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Harefield NHS Foundation Trust, Sydney Street, SW3 6NP London, UK. AD - National Heart and Lung Institute, Imperial College London, UK. FAU - Alonso-Gonzalez, Rafael AU - Alonso-Gonzalez R AD - Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Harefield NHS Foundation Trust, Sydney Street, SW3 6NP London, UK. AD - National Heart and Lung Institute, Imperial College London, UK. FAU - Swan, Lorna AU - Swan L AD - Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Harefield NHS Foundation Trust, Sydney Street, SW3 6NP London, UK. AD - National Heart and Lung Institute, Imperial College London, UK. FAU - Uebing, Anselm AU - Uebing A AD - Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Harefield NHS Foundation Trust, Sydney Street, SW3 6NP London, UK. AD - National Heart and Lung Institute, Imperial College London, UK. FAU - Diller, Gerhard-Paul AU - Diller GP AD - Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Harefield NHS Foundation Trust, Sydney Street, SW3 6NP London, UK. AD - National Heart and Lung Institute, Imperial College London, UK. AD - Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Albert-Schweitzer-Str. 33, Muenster, 48149, Germany. FAU - Gatzoulis, Michael A AU - Gatzoulis MA AD - Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Harefield NHS Foundation Trust, Sydney Street, SW3 6NP London, UK. AD - National Heart and Lung Institute, Imperial College London, UK. FAU - Dimopoulos, Konstantinos AU - Dimopoulos K AD - Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Harefield NHS Foundation Trust, Sydney Street, SW3 6NP London, UK. AD - National Heart and Lung Institute, Imperial College London, UK. LA - eng PT - Journal Article PL - England TA - Eur Heart J Qual Care Clin Outcomes JT - European heart journal. Quality of care & clinical outcomes JID - 101677796 SB - IM MH - Adult MH - *American Heart Association MH - Exercise Test MH - Exercise Tolerance/*physiology MH - Female MH - Heart Defects, Congenital/*classification/mortality/physiopathology MH - Humans MH - Male MH - New York MH - Prognosis MH - Retrospective Studies MH - Survival Rate/trends MH - United Kingdom/epidemiology MH - United States OTO - NOTNLM OT - Cardiopulmonary exercise test OT - Congenital heart diseases OT - Mortality OT - NYHA OT - Prognosis EDAT- 2017/09/28 06:00 MHDA- 2019/02/05 06:00 CRDT- 2017/09/27 06:00 PHST- 2017/07/20 00:00 [received] PHST- 2017/08/16 00:00 [accepted] PHST- 2017/09/28 06:00 [pubmed] PHST- 2019/02/05 06:00 [medline] PHST- 2017/09/27 06:00 [entrez] AID - 4083514 [pii] AID - 10.1093/ehjqcco/qcx031 [doi] PST - ppublish SO - Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):51-58. doi: 10.1093/ehjqcco/qcx031.